文摘
LpxC is a zinc amidase that catalyses the second step of lipid A biosynthesis in Gram-negativebacteria. Oxazolines incorporating a hydroxamic acid, which is believed to coordinate to the single essentialzinc ion, at the 4-position are known inhibitors of this enzyme. Some of these enzyme inhibitors exhibitantibacterial activity through their inhibition of LpxC. We recently developed a method for the synthesis ofoxazolines using resin capture and ring-forming release that eliminates traditional purification steps andcan be used in high-throughput synthesis. Using our method, oxazoline hydroxamates with diverse2-substituents were prepared in library form as candidate inhibitors for LpxC. Two conventional methodsfor oxazoline synthesis were also applied to generate more than 70 compounds. The groups at the 2-positionincluded a wide variety of substituted aromatic rings and a limited selection of alkyl groups. These compoundswere screened against wild-type and LpxC inhibitor-sensitive strains of Escherichia coli, as well as wild-type Pseudomonas aeruginosa. Inhibition of the E. coli LpxC enzyme was also investigated. A broadcorrelation between enzyme inhibitory and antibacterial activity was observed, and novel compounds werediscovered that exhibit antibacterial activity but fall outside earlier-known structural classes.